Skip to content

Strength Training and ADLs in Childhood Leukemia and Lymphoma Patients

Effects of a Specific Strength Training Regarding Activities of Daily Living (ADLs) Associated With Movement During Treatment of Leukemia or Non-Hodgkin Lymphoma in Childhood and Adolescence

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03934060
Enrollment
40
Registered
2019-05-01
Start date
2017-09-01
Completion date
2021-02-25
Last updated
2021-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancer

Keywords

exercise, strength training, activities of daily living, childhood cancer, leukemia, Non-Hodgkin lymphoma

Brief summary

Reduced activity levels and reduced muscular strength could severely impair the activities of daily living (ADLs) in pediatric leukemia and Non-Hodgkin lymphoma patients. Increased muscle strength is associated with improved accomplishment of ADLs and consequently greatest possible normality, autonomy and mobility. Primary outcome of this RCT (n=20/20) is the analysis of effects of a treatment-associated and close to every day life strength training (2-3 times/week) compared to a general exercise program (standard care).

Interventions

OTHERExercise

specific strength training

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with Acute Leukemia or Non-Hodgkin Lymphoma * Diagnosed and/or treated at the Kinderklinik München Schwabing, Technische Universität München * Informed consent as documented by signature

Exclusion criteria

* Medical contraindications regarding strength training (e.g. risk of bleeding, ...) * Contraindications to one of the inclusion criteria mentioned above * Inability to follow the procedures and understand the intervention and assessments of this study, e.g. due to cognitive impairment, language problems, psychological disorders etc.

Design outcomes

Primary

MeasureTime frameDescription
Change of score of the Activities Scale for Kids - performance versionChange of the ASK score from baseline to 3 months, change from 3 months to 6 months, change from 6 months to 12 monthsThe ASK - Activities Scale for Kids performance version by NL Young assesses an overall summary score (0-100) of self-reported activities of daily living in children and adolescents. The scale monitors changes associated with therapeutic interventions. Higher values represent a better outcome. The ASK contains 30 items in 7 sub-domains (personal care, dressing, other skills, locomotion, play, standing skills and transfer).

Secondary

MeasureTime frameDescription
Change of motor performance analyzed with the Motor performance test in Pediatiric Oncology (MOON)Change of motor performance from baseline to 6 monthsMotor performance is assessed by the MOON-test, a tool to examine motor performance abilities in children and adolescents during and after cancer treatment. There's no summary score; reference values of healthy children enable comparison of the tested children.
Change of level of physical activityChange of physical activity level from baseline to 3 months, from 3 to 6 months, from 6 to 12 monthsPhysical activity is assessed using an accelerometer (movisens) for the period of 7 days.
Change in performance in a parkour in activities of daily livingChange of score in the parkour from baseline to 6 monthsA standardized parkour with tasks imitating activities of daily living is used to objectively verify the ASK score. Points from 0-4 are counted for each task depending on quality of movement (0 = task can not be completed, 1 = task can be completed with help, 2 = task can be completed with several attempts, 3 = task can be completed with only little effort, 4 = task can be completed without any problems or effort). There are no reference values for the parkour, but intra-individual changes are analyzed.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026